Insulin glargine, recombinant Subcutaneous and Larotrectinib Capsules
Determining the interaction of Insulin glargine, recombinant Subcutaneous and Larotrectinib Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: larotrectinib
Brand name: Vitrakvi
Synonyms: Larotrectinib
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine, recombinant Subcutaneous-Larotrectinib Oral Solution
- Insulin glargine, recombinant Subcutaneous-Larotrectinib Sulfate
- Insulin glargine, recombinant Subcutaneous-Lartruvo
- Insulin glargine, recombinant Subcutaneous-Larynex
- Insulin glargine, recombinant Subcutaneous-Laryng-O-Jet
- Insulin glargine, recombinant Subcutaneous-Laryngesic
- Larotrectinib Capsules-Insulin glulisine
- Larotrectinib Capsules-Insulin Glulisine (Cartridges and Pens)
- Larotrectinib Capsules-Insulin Glulisine (Vials)
- Larotrectinib Capsules-Insulin glulisine Subcutaneous
- Larotrectinib Capsules-Insulin human inhaled Inhalation
- Larotrectinib Capsules-Insulin human regular Injection